Recombinant Protective Antigen Anthrax Vaccine Improves Survival When Administered as a Postexposure Prophylaxis Countermeasure With Antibiotic in the New Zealand White Rabbit Model of Inhalation Anthrax

Clinical and Vaccine Immunology - United States
doi 10.1128/cvi.00240-12

Related search